BRWA
ROSG

B. Riley Wealth Advisors’s Rosetta Genomics Ltd. ROSG Stock Holding History

B. Riley Wealth Advisors’s Portfolio ROSG Stock Details ROSG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-42,736
Closed -$1.11M – 2291
2014
Q2 		$1.11M Buy
42,736
+11,979
+39% +$593K 0.26% 74
2014
Q1 		$1.84M Buy
+30,757
New +$1.59M 0.56% 35

Other funds holding ROSG

Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
HCM
Highlander Capital Management Short Hills, New Jersey $292M AUM 22.24% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
SKK
Shepherd Kaplan Krochuk Boston, Massachusetts $119M AUM 8.32% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

B. Riley Wealth Advisors's ROSG Position: Q3 2014 in Review

B. Riley Wealth Advisors sold out of Rosetta Genomics Ltd. (ROSG) in Q3 2014, closing a stake of 42,736 shares — an estimated $1.11M sold.

B. Riley Wealth Advisors first reported a position in ROSG in Q1 2014 and held it in 2 quarters. The position peaked at $1.84M in Q1 2014. 14 funds tracked by Wall St. Rank hold ROSG as of Q3 2014.

  • B. Riley Wealth Advisors reported no remaining Rosetta Genomics Ltd. position as of Q3 2014 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 42,736 Rosetta Genomics Ltd. shares in Q3 2014, an estimated $1.11M.
  • B. Riley Wealth Advisors first reported a position in Rosetta Genomics Ltd. in Q1 2014 and held it in 2 quarters.
  • B. Riley Wealth Advisors's Rosetta Genomics Ltd. position peaked at $1.84M in Q1 2014.
  • 14 funds tracked by Wall St. Rank held Rosetta Genomics Ltd. as of Q3 2014.

Based on B. Riley Wealth Advisors's 13F filing for Q3 2014, filed 14 Nov 2014.